Back to search

Phase I Study of Recombinant CEA Vaccinia Virus Vaccine with Post Vaccination CEA Peptide Challenge. Medical University of South Carolina, Charleston, South Carolina

Data up to Jan 2025

Published1996
Citations48
References21

Total Citations Per Year

Abstract

References (21)

Cancer statistics, 1992

1992 • 540 citations

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1984 • 448 citations

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

1983 • 422 citations

Vaccinia Virus: A Tool for Research and Vaccine Development

1991 • 410 citations

Identification of an Antigen from Normal Human Tissue That Crossreacts with the Carcinoembryonic Antigen

1972 • 376 citations

Vaccinia Virus Expression Vectors

1987 • 272 citations

Cea-related antigens: Molecular biology and clinical significance

1985 • 268 citations

Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence

1987 • 259 citations

Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

1984 • 234 citations

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1992 • 212 citations

Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions.

1990 • 121 citations

Tumour prevention and rejection with recombinant vaccinia

1987 • 101 citations

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.

1988 • 98 citations

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.

1987 • 98 citations

Carcinoembryonic antigen in patients with carcinoma of the lung

1973 • 97 citations

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

1990 • 95 citations

A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)

1991 • 87 citations

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma

1987 • 69 citations

Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97

1988 • 40 citations

Combination chemotherapy of Hodgkin's disease

1974 • 35 citations

CEA-containing immune complexes in sera of patients with colorectal and breast cancer ? analysis of complexed immunoglobulin classes

1988 • 30 citations

Cited By (0)

Loading...
Phase I Study of Recombinant CEA Vaccinia Virus Vaccine with Post Vaccination CEA Peptide… (1996) – Human Gene Therapy | Metascience Observatory Explorer